Please login to the form below

Not currently logged in
Email:
Password:

President Trump

This page shows the latest President Trump news and features for those working in and with pharma, biotech and healthcare.

NCI head Sharpless named as interim FDA chief

NCI head Sharpless named as interim FDA chief

A permanent successor must be nominated by President Trump and confirmed by the Senate, however, and Sharpless isn’t the only name linked to the FDA’s top job. ... the FDA,” adding: “It will be an honour to advance the FDA’s critical public

Latest news

  • Trump budget targets rebates, out-of-pocket costs Trump budget targets rebates, out-of-pocket costs

    President Trump has sent a $4.75trn annual budget proposal to Congress that includes cuts to spending on Medicare and Medicaid, as well as a raft of measures aimed at reducing ... At a White House press conference Office of Management and Budget (OMB)

  • FDA chief Scott Gottlieb to step down FDA chief Scott Gottlieb to step down

    The news has nevertheless come as a surprise to the pharma and biotech sectors, where Gottlieb has been viewed as a great success since being appointed by President Trump in 2017. ... Harvard University professor and FDA expert Daniel Carpenter told the

  • Novartis back in the spotlight over Trump/Cohen links Novartis back in the spotlight over Trump/Cohen links

    President Trump’s former lawyer Michael Cohen has explained why Novartis paid him $1.2m to act as a consultant on the Trump administration, to the embarrassment of the drugmaker. ... He told the House Oversight committee members that Novartis’ $1.2m

  • Fireworks likely at Senate drug pricing hearing today Fireworks likely at Senate drug pricing hearing today

    The hearing comes against the backdrop of a recent probe into insulin pricing introduced by Grassley and his Democrat counterpart on the committee, Ron Wyden, as well as President Trump’s ... Trump’s blueprint contains some fairly unpalatable

  • CEOs agree to Congressional grilling on US drug prices CEOs agree to Congressional grilling on US drug prices

    While many congressmen and women don’t see eye to eye with President Trump on many policies, he has given renewed life to the debate on drug prices, even if there ... During his State of the Union speech on Tuesday, Trump repeated his view that it was

More from news
Approximately 4 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Current global president, worldwide research and development and medical, Mikael Dolsten, will also become chief medical officer. ... This was because Read had agreed to reverse previously announced price increases after being telephoned by President

  • Change in the pharma industry is inevitable Change in the pharma industry is inevitable

    Its highly fragmented nature leaves it ripe for further M&A activity - led by emboldened and cash-rich US firms if President Trump, via a low ‘repatriation tax’, opens the door ... And then there is the problem of public opinion. “We have a

  • Focus on the fundamentals Focus on the fundamentals

    Brexit, Trump becoming president and in France a movement that did not exist two years ago holding the parliamentary majority.

  • Pharma deals continue to slide Pharma deals continue to slide

    With the dysfunctional political system in the US it is hardly surprising that eight months following President Trump’s inauguration, the repeal of Obamacare has been dropped and the pricing and ... Similarly, the Euro is now around 10% stronger

  • US health reforms US health reforms

    One of the things I think industry is worried about is if Congress and the President can’t get a health bill passed, do they turn to drug pricing because that ... added. President Trump himself has frequently called for lower drug prices. “Once

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics